These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 33274240)
21. High expression of FOXP3 in primary melanoma is associated with tumour progression. Gerber AL; Münst A; Schlapbach C; Shafighi M; Kiermeir D; Hüsler R; Hunger RE Br J Dermatol; 2014 Jan; 170(1):103-9. PubMed ID: 24116716 [TBL] [Abstract][Full Text] [Related]
22. Regulatory T Cells: the Many Faces of Foxp3. Georgiev P; Charbonnier LM; Chatila TA J Clin Immunol; 2019 Oct; 39(7):623-640. PubMed ID: 31478130 [TBL] [Abstract][Full Text] [Related]
23. [Impact of СD8/FoxP3 T lymphocyte ratio in the peritumoral area of primary cutaneous melanoma on the prognosis of the disease]. Bozhchenko YA; Vishnevskaya YV; Pokataev IA; Kokosadze NV; Demidov LV Arkh Patol; 2016; 78(4):27-31. PubMed ID: 27600779 [TBL] [Abstract][Full Text] [Related]
24. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers. Saito T; Nishikawa H; Wada H; Nagano Y; Sugiyama D; Atarashi K; Maeda Y; Hamaguchi M; Ohkura N; Sato E; Nagase H; Nishimura J; Yamamoto H; Takiguchi S; Tanoue T; Suda W; Morita H; Hattori M; Honda K; Mori M; Doki Y; Sakaguchi S Nat Med; 2016 Jun; 22(6):679-84. PubMed ID: 27111280 [TBL] [Abstract][Full Text] [Related]
25. FOXP3+ T regulatory lymphocytes in primary melanoma are associated with BRAF mutation but not with response to BRAF inhibitor. Leslie C; Bowyer SE; White A; Grieu-Iacopetta F; Trevenen M; Iacopetta B; Amanuel B; Millward M Pathology; 2015 Oct; 47(6):557-63. PubMed ID: 26308130 [TBL] [Abstract][Full Text] [Related]
26. The ratio of intra-tumoral regulatory T cells (Foxp3+)/helper T cells (CD4+) is a prognostic factor and associated with recurrence pattern in gastric cardia cancer. Kim HI; Kim H; Cho HW; Kim SY; Song KJ; Hyung WJ; Park CG; Kim CB J Surg Oncol; 2011 Dec; 104(7):728-33. PubMed ID: 21792941 [TBL] [Abstract][Full Text] [Related]
27. The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Wolf D; Wolf AM; Rumpold H; Fiegl H; Zeimet AG; Muller-Holzner E; Deibl M; Gastl G; Gunsilius E; Marth C Clin Cancer Res; 2005 Dec; 11(23):8326-31. PubMed ID: 16322292 [TBL] [Abstract][Full Text] [Related]
28. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis. Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566 [TBL] [Abstract][Full Text] [Related]
29. Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma. Sabbatino F; Scognamiglio G; Liguori L; Marra A; Anniciello AM; Polcaro G; Dal Col J; Caputo A; Peluso AL; Botti G; Zeppa P; Ferrone S; Pepe S Front Immunol; 2020; 11():561390. PubMed ID: 33117345 [TBL] [Abstract][Full Text] [Related]
30. Remodeling of the tumor microenvironment via disrupting Blimp1 Dixon ML; Luo L; Ghosh S; Grimes JM; Leavenworth JD; Leavenworth JW Mol Cancer; 2021 Nov; 20(1):150. PubMed ID: 34798898 [TBL] [Abstract][Full Text] [Related]
31. The vaccine-site microenvironment induced by injection of incomplete Freund's adjuvant, with or without melanoma peptides. Harris RC; Chianese-Bullock KA; Petroni GR; Schaefer JT; Brill LB; Molhoek KR; Deacon DH; Patterson JW; Slingluff CL J Immunother; 2012 Jan; 35(1):78-88. PubMed ID: 22130163 [TBL] [Abstract][Full Text] [Related]
32. Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression. Strauss L; Bergmann C; Szczepanski MJ; Lang S; Kirkwood JM; Whiteside TL J Immunol; 2008 Mar; 180(5):2967-80. PubMed ID: 18292519 [TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human. Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651 [TBL] [Abstract][Full Text] [Related]
34. Wild-type FOXP3 is selectively active in CD4+CD25(hi) regulatory T cells of healthy female carriers of different FOXP3 mutations. Di Nunzio S; Cecconi M; Passerini L; McMurchy AN; Baron U; Turbachova I; Vignola S; Valencic E; Tommasini A; Junker A; Cazzola G; Olek S; Levings MK; Perroni L; Roncarolo MG; Bacchetta R Blood; 2009 Nov; 114(19):4138-41. PubMed ID: 19738030 [TBL] [Abstract][Full Text] [Related]
35. T-cell proliferation and forkhead box P3 expression in human T cells are dependent on T-cell density: physics of a confined space? Bernardo D; Al-Hassi HO; Mann ER; Tee CT; Murugananthan AU; Peake ST; Hart AL; Knight SC Hum Immunol; 2012 Mar; 73(3):223-31. PubMed ID: 22248741 [TBL] [Abstract][Full Text] [Related]
36. Immunoregulatory Forkhead Box Protein p3-Positive Lymphocytes Are Associated with Overall Survival in Patients with Pancreatic Neuroendocrine Tumors. de Reuver PR; Mehta S; Gill P; Andrici J; D'Urso L; Clarkson A; Mittal A; Hugh TJ; Samra JS; Gill AJ J Am Coll Surg; 2016 Mar; 222(3):281-7. PubMed ID: 26809747 [TBL] [Abstract][Full Text] [Related]
37. Chronic lymphocytic leukaemia cells drive the global CD4+ T cell repertoire towards a regulatory phenotype and leads to the accumulation of CD4+ forkhead box P3+ T cells. Piper KP; Karanth M; McLarnon A; Kalk E; Khan N; Murray J; Pratt G; Moss PA Clin Exp Immunol; 2011 Nov; 166(2):154-63. PubMed ID: 21985361 [TBL] [Abstract][Full Text] [Related]
38. Tumoral FOXP3 has potential oncogenic function in conjunction with the p53 tumor suppressor protein and infiltrated Tregs in human breast carcinomas. Won KY; Kim HS; Sung JY; Kim GY; Lee J; Park YK; Kim YW; Suh JH; Lim SJ Pathol Res Pract; 2013 Dec; 209(12):767-73. PubMed ID: 24071443 [TBL] [Abstract][Full Text] [Related]
39. The vast majority of lymphocytes infiltrating primary cutaneous melanoma express the CD27 costimulatory receptor: implications for melanoma progression. Pepe CA; Ricci R; Cortelazzi C; Mori G; Zambito F; Campanini N; Aimi F; Santoro S; Lombardi M; Santini M; de Panfilis G Eur J Dermatol; 2011; 21(2):178-83. PubMed ID: 21382782 [TBL] [Abstract][Full Text] [Related]
40. Recovery of CD226-TIGIT Long Y; Wang C; Xia C; Li X; Fan C; Zhao X; Liu C Immunol Lett; 2020 Feb; 218():30-39. PubMed ID: 31883787 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]